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What are infectious proteins?
The infectious isoform of the mammalian prion protein, PrPSc, was the first protein to be iden-
tified as an infectious protein [1] (Table 1). PrPSc can be transmitted both from cell-to-cell and
between animals or individuals and causes an invariably fatal, neurodegenerative disease [2].
Fungal prions, which are unrelated to the mammalian prion protein, convey cytosolic inheri-
tance based on different protein folding states and are transmitted from mother to daughter
cell during cell division or in the course of cytoplasmic fusion events [3,4]. In recent years,
other neurodegenerative diseases, such as Alzheimer disease and Parkinson disease, were also
recognized as being spread by cell-to-cell transmission of protein aggregates, although the
infectivity of these particles is a matter of debate [5]. In these cases, proteins other than the
prion protein (e.g., Aβ, microtubule-associated protein tau, α-synuclein, etc.) are prone to mis-
folding and aggregation (Table 1) and were subsequently labeled as prions, prionoids, or
prion-like proteins, depending on the preferences of the authors and reflecting the open ques-
tion with respect to infectivity [6].
In most cases, these proteins form amyloid or amyloid-like fibrils, but other aggregation
states, such as oligomers, amorphous aggregates, and 2-D crystals, have been observed. The
insolubility and aggregated nature of amyloids and infectious prion particles complicates their
structural characterization by X-ray crystallography, etc., but circular dichroism (CD) and
Fourier-transform infrared (FTIR) spectroscopies indicated that infectious proteins generally
contain predominantly β-sheets [2,5]. Therefore, often, a variety of techniques are used in
combination to elucidate the structure of these infectious proteins. Those that have provided
the most useful high-resolution results will be discussed in this article.
Five approaches
Electron microscopy and related techniques
Negative stain electron microscopy is widely used to characterize the aggregation state of amy-
loids and other polymers. It is a fast and straightforward tool to assess aggregate morphology
and to measure their size in two dimensions but is limited to low-resolution observations.
Height measurements are difficult to make via this approach and are more reliably done
through scanning probe microscopies (also known as atomic force microscopy [AFM]). Pro-
tein aggregates that display intrinsic symmetry, such as helical amyloid fibrils or 2-D crystals,
can be used to extract more detailed information about the aggregated protein (e.g., [7,8]). In
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these cases, image processing takes advantage of the repeating structure and can extract molec-
ular details through averaging that are not readily visible. Electron tomography can rapidly
provide 3-D tomograms of the observed specimens, but the dose fractionation that is necessary
to collect the different view angles limits the resolution of the reconstructed volumes [9,10].
High-resolution electron microscopy studies require the use of cryo low-dose imaging tech-
niques. With the advent of direct electron detectors, unprecedented structural detail can be
visualized, which, under optimal conditions, can reach atomic resolution [11,12]. The added
sensitivity that is provided by these new detectors is revolutionizing electron cryomicroscopy
and the structural details that can be obtained from even challenging samples, such as protein
aggregates (Fig 1) [10]. However, the structural heterogeneity that is commonly seen with pro-
tein aggregates often limits the resolution that can be obtained, and this also applies to individ-
ual amyloid fibrils of infectious prions [10,13].
Diffraction techniques
Protein aggregates, including those composed of infectious proteins, are also amenable to
structural analyses via diffraction techniques, such as small angle X-ray scattering (SAXS), X-
ray crystallography, and X-ray fiber diffraction. The latter technique is often used to detect the
characteristic 4.8 Å cross-β signature of amyloid fibrils [14], which is a defining criterion com-
monly used in biophysics for the term “amyloid.” The need to achieve sufficient sample orien-
tation is an ongoing challenge for X-ray fiber diffraction analyses of amyloid fibrils, but well-
oriented samples can reveal the necessary structural details to define the molecular dimensions
and structural architecture of different amyloid forms [15,16]. X-ray crystallography has more
stringent demands, as it requires the protein to form well-ordered 3-D crystals, which is nearly
impossible to achieve except with small amyloidogenic peptides [17].
Table 1. Infectious prions and prion-like proteins.









Prion diseases (e.g., Kuru, Creutzfeldt-Jakob disease, bovine
spongiform encephalopathy, chronic wasting disease, scrapie,
etc.)
PrPC PrPSc yes yes yes
Yeast prion1 Ure2p [URE3] yes yes2
Yeast prion1 Sup35p [PSI+] yes yes2
Yeast prion1 Rnq1p [PIN+] yes yes2
Heterokaryon incompatibility1 HET-s [HET-s] yes yes yes
Alzheimer disease APP Aβ yes yes no4
Alzheimer disease & tauopathies Tau PHF-Tau yes yes no4
Parkinson disease α-synuclein3 α-synuclein3 yes yes no4
Lou Gehrig disease SOD13 SOD13 yes yes no





Huntington disease huntingtin huntingtin no yes no
1 not a disease, but a metabolic/mating-type phenotype
2 unicellular organism, transmission occurs during cell division from mother to daughter cell
3 other proteins have also been implicated in these diseases
4 evidence suggests the possibility for transmission through iatrogenic or environmental mechanisms, but these claims are still under vigorous discussion
https://doi.org/10.1371/journal.ppat.1006229.t001
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In contrast, SAXS provides a measure of the sample/aggregate size without the need for
sample orientation. In fact, the random orientation of the protein aggregates in solution allows
calculation of the overall aspect ratio of the aggregate. Therefore, a sufficiently dispersed sam-
ple can provide molecular or protein aggregate dimensions via the radius of gyration [18].
Nuclear magnetic resonance spectroscopy
A large array of spectroscopic techniques has been applied to the study of protein aggregates,
including infectious prions. One particularly powerful technique is nuclear magnetic reso-
nance (NMR), because it provides single-residue resolution and can be applied to both soluble
species and insoluble aggregates. In case of insoluble particles, the slow tumbling time of the
aggregates has to be taken into account. Therefore, solution-state NMR is best combined with
hydrogen/deuterium exchange assays, in which the exchange rate of hydrogen atoms, which
participate in peptide bonds, with the solvent strongly depends on the local secondary struc-
ture in the aggregate. In particular, hydrogen atoms within β-strands participate in relatively
stable hydrogen bonds and exchange very slowly. This makes hydrogen/deuterium exchange
coupled with solution NMR spectroscopy a powerful tool to identify the location of the regular
secondary structure elements in prion aggregates [19].
The most powerful experimental technique to characterize heterogeneous protein aggre-
gates and infectious prions to date is solid-state NMR spectroscopy [20,21]. Solid-state NMR
Fig 1. Electron cryomicroscopy analysis of infectious prion protein amyloid fibrils. (A) Section of a cryo electron
micrograph showing prion fibrils lacking the glycosylphosphatidylinositol (GPI) anchor. A single isolated and twisted fibril
used for the 3-D reconstruction is enclosed by a black box. (B) Close-up view of the isolated prion fibril. (C) Reprojected
image of the 3-D fibril map for comparison with the unprocessed image (B). (D) 3-D reconstruction of the GPI-anchorless
prion fibril. (E) Cross section of the reconstructed fibril showing two distinct protofilaments. (F) Contoured density maps of
the cross section with lines contoured at increasing levels of 0.125 σ. (G) Cartoon depicting the proposed configuration of
the polypeptide chains in the prion fibril. Please note that this is not an atomistic model. (H) Close-up view of the possible ß-
sheet stacking in a four-rung ß-solenoid architecture for illustration purposes only. Different colors represent different ß-
solenoid rungs. Characteristic distances of the four-rung ß-solenoid architecture are labeled. Figure adapted from [10].
https://doi.org/10.1371/journal.ppat.1006229.g001
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spectroscopy has now reached a level at which it can reliably determine the 3-D structure of
single molecules in amyloid fibrils [22–25]. In combination with information from other tech-
niques, such as electron microscopy and modeling, this approach can also provide insights
into the higher order arrangements of molecules in prion aggregates [26,27].
Mass spectrometry
Mass spectrometry analysis of peptide fragments obtained under denaturing, exchange-
quenching conditions has been used to assess the global exchange of short stretches of a given
protein. Application of such an approach to GPI-anchorless PrPSc showed an overall very low
rate of exchange of a stretch spanning from position ~81 to ~226, which is suggestive of a high
content of β-sheet secondary structure and tight packing. Slightly higher exchange of some
short regions within this stretch suggests the presence of short loops connecting short β-
strands [28]. Similar results have been obtained more recently for infectious, recombinant
PrPSc, suggesting a common structure for all infectious PrPSc forms [29], which is very differ-
ent from that of noninfectious recombinant amyloids [28].
Chemical probes
Chemical probes have been successfully used to obtain structural information of proteins diffi-
cult to study by other means. Typical approaches include surface labeling, which provides
information about accessibility of specific amino acids, and cross-linking with bifunctional
reagents, which provides upper limits on the distance between pairs of accessible residues.
Identification of modified sites is typically achieved by mass spectrometry after tryptic diges-
tion [30].
Surface labeling of PrPSc with tyrosine-specific reagents showed that its C-terminal region
has suffered a very substantial structural rearrangement, contrary to the hypothesis of con-
served C-terminal α-helices [31]. PrPSc has also been probed with cross-linking reagents.
Experiments using bis (sulfosuccinimidyl) suberate (BS3) showed that the amino termini of
successive PrP 27–30 units in a PrP 27–30 stack are within 11.4 Å [32]. While such a distance
constraint was interpreted at the time as a limitation to the maximum number of rungs in the
PrPSc β-solenoid, it is fully compatible with head-to-head stacking of PrPSc units [10].
In summary, chemical probing should be seen as a complement to other techniques that
provide a general view of the architecture of infectious proteins. Recent advances in sensitivity
and accuracy of mass spectrometry methods, such as Fourier-transform instruments and
chemical footprinting with synchrotron radiation, has opened up exciting new possibilities
[30].
Conclusion
Recent technological advances have provided a wealth of data on the structures of patholog-
ically aggregated, infectious proteins involved in Alzheimer disease, Parkinson disease, and
the prion diseases. In the former cases, the structure of the aggregated proteins (Aβ and α-
synuclein) were found to adopt an in-register β-sheet structure [24,25]. In contrast, for the
archetypical prion diseases (PrPSc), a four-rung β-solenoid architecture was observed [10,15],
in agreement with lower-resolution approaches [18,28,31,32]. The ability to generate disease-
relevant protein conformers in vitro, in combination with solid-state NMR and other analysis
techniques, was crucial for determining the high-resolution structures of misfolded Aβ and α-
synuclein [24,25]. A similar approach may provide high-resolution structural information
about PrPSc in the future.
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